Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans

Prostate Cancer and Prostatic Diseases

Volumn 10, Issue 3, 2007, Pages 261-269

  Bogen, K T ^a   Keating II, G A ^a   Chan, J M ^b   Paine, L J ^c   Simms, E L ^c   Nelson, D O ^a   Holly, E A ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Summitt Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; PROSTATE SPECIFIC ANTIGEN; SATURATED FATTY ACID;

ADULT; AFRICAN AMERICAN; AGED; ANTIGEN DETECTION; ARTICLE; CALORIC INTAKE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOKING; DIETARY INTAKE; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; FAT INTAKE; FOOD ANALYSIS; FOOD COMPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; CARCINOGENS; DIET; HUMANS; IMIDAZOLES; MALE; MEAT; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 34548457350     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500941     Document Type: Article

References (128)

1. Thompson LH, Tucker JD, Stewart SA, Christensen ML, Salazar EP, Carrano AV et al. Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus salmonella mutagenicity. Mutagen 1987; 2: 483-487.
2. Keating GA, Layton DW, Felton JS. Factors determining dietary intakes of heterocyclic amines in cooked foods. Mutat Res 1999; 443: 149-156.
3. Keating GA, Sinha R, Layton D, Salmon CP, Knize MG, Bogen KT et al. Comparison of heterocyclic amine levels in home-cooked meats with exposure indicators. Cancer Causes Control 2000; 11: 731-739.
4. Bogen KT. Cancer potencies of heterocyclic amines found in cooked foods. Food Chem Toxicol 1994; 32: 505-515.
5. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton J. Cancer risk assessment of heterocyclic amines in cooked foods: An analysis and implications for research. Carcinogenesis 1995; 16: 39-52.
6. Felton JS, Knize MG, Wood C, Wuebbles BJ, Healy SK, Stuermer DH et al. Isolation and characterization of new mutagens from fried ground beef. Carcinogenesis 1984; 5: 95-102.
7. Felton JS, Knize MG, Shen NH, Andresen BD, Bjeldanes LF, Hatch FT. Identification of the mutagens in cooked beef. Environ Health Perspect 1986; 67: 17-24.
8. Felton JS, Pais P, Salmon CP, Knize MG. Chemical analysis and significance of heterocyclic aromatic amines. Z Lebensm Unters Forsch A 1998; 207: 434-440.
9. Felton JS, Knize MG. Heterocyclic-amine mutagens/carcinogens in foods. In: Cooper CS, Grover PL (eds). Handbook of Experimental Pharmacology, 94/1. Springer-Verlag: Berlin, 1990, pp 471-502.
10. Felton JS, Knize MG. New mutagens from cooked food. In: Pariza M, Aeschbacher H-U, Felton JS, Sato S (eds). Mutagens and Carcinogens in the Diet. Wiley-Liss Inc.: New York, 1990, pp 19-38.
11. Sinha R, Rothman N, Brown ED, Salmon CP, Knize MG, Swanson CA et al. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-bpyridine occur in chicken but are dependent on the cooking method. Cancer Res 1995; 55 4516-4519.
12. Esumi H, Ohgaki H, Kohzen E, Takayama S, Sugimura T. Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine. Cancer Res 1989; 80: 1176-1178.
13. Ochiai M, Ogawa K, Wakabayashi K, Sugimura T, Nagase S, Esumi H et al. Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4-5-b]pyridine in Nagase analbuminemic rats. Jap J Cancer Res (Gann) 1991; 82: 363-366.
14. Ohgaki H, Takayama S, Sugimura T. Carginogenicity of heterocyclic amines in cooked foods. Mutat Res 1991; 259: 339-410.
15. Ito N, Hasegawa R, Imaida K, Tamano S, Hagiwara A, Hirose M et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 1997; 376: 107-114.
16. Ito N, Hasegawa R, Sano, M, Tamano S, Esumi H, Takayama S et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP). Carcinogenesis 1991; 12: 1503-1506.
17. Hasegawa R, Sano M, Tamano S, Imaida K, Shirai T, Nagao M et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Carcinogenesis 1993; 14: 2523-2557.
18. Ghoshal A, Preisegger K-H, Takayama T, Thorgeirsson S, Snyderwine EG. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5,-b pyridine and effect of dietary fat. Carcinogenesis 1994; 15 2429-2433.
19. Shirai T, Sano, M, Tamano S, Takahashi S, Hirose M, Futakushi M et al. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997; 57: 195-198.
20. Shirai T, Cui L, Takahashi S, Futakuchi M, Asamoto M, Kato K et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate. Cancer Lett 1999; 143: 217-221.
21. Gooderham NJ, Zhu H, Lauber S, Boyce A, Creton S. Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4-5-b]pyridine (PhIP). Mutat Res 2002; 506-507: 91-99.
22. U.S. Department of Health and Human Services (USDHHS). Final Report on Carcinogens Background Document for Selected Heterocyclic Amines: PhIP, MeIQ. and MeIQx. September 12, 2002. Prepared by the Technology Planning and Management Corp for the USDHHS National Toxicology Program, Research Triangle Park NC. ntp.neihs.nih.gov/ntp/newhomeroc/roc11/HCAsPub.pdf. 2002.
23. Thorgeirsson SS. Metabolic determinants in the carcinogenicity of aromatic amines. In: Greim H, Jung R, Kramer M, Marquardt H, Oesch F (eds). Biochemical Basis of Chemical Carcinogenesis. Raven Press: New York, NY, 1984, pp. 47-56.
24. Thorgeirsson SS, Glowinsk IB, McManus ME. Metabolism, mutagenicity and carcinogenicity of aromatic amines. In: Hodgson E, Bend JR, Philpot RM (eds). Reviews in Biochemical Toxicology 5. Elsevier Biomedical: New York, Amsterdam, Oxford, 1983, pp 349-386.
25. Rosenkranz HS, Mermeistein R. The genotoxicity, metabolism and carcinogenicity of nitrated polycyclic aromatic hydrocarbons. J Environ Sci Health 1985; C3: 221-272.
26. Sato S, Negishi C, Umemoto A, Sugimura T. Metabolic aspects of pyrolysis mutagens in food. Environ Health Perspect 1986; 67: 105-109.
27. Kato R, Yamazoe Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked food and amino acid pyrolysates. Jap J Cancer Res (Gann) 1987; 81: 10-14.
28. Snyderwine EG, Battula N. Selective mutagenic activation by cytochrome P3-450 of carcinogenic arylamines found in foods. J Natl Cancer Inst 1989; 81: 223-227.
29. McManus ME, Burgess WM, Veronese ME, Hugget A, Quattrochi LC, Tukey RH. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by cytochromes P450. Cancer Res 1990; 50: 3367-3376.
30. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF. Metabolic activation of carcingenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991; 12: 1839-1845.
31. Davis CD, Schut HAJ, Adamson RH, Thorgeirsson UP, Thorgeirsson SS, Snyderwine EG. Mutagenic activation of IQ, PhIP and MelQx by hepatic microsomes from rat, monkey and man: Low mutagenic activation of MelQx in cynomolgous monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis 1993; 14: 61-65.
32. Kaderlik KR, Minchin RF, Mulder GJ, Ilett KF, Daugaard-Jenson M, Teitel CH et al. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis 1994; 15: 1703-1709.
33. Kaderlik KR, Mulder GJ, Shaddock JG, Casciano DA, Teitel CH, Kadlubar FF. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenyli-midazo[4,9-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis 1994; 15 1711-1716.
34. Takahashi S, Tamano S, Hirose M, Kimoto N, Ikeda Y, Sakakibara M et al. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine (PhIP): Detection in paraffin-embedded sections and tissue distribution. Cancer Res 1998; 58: 4307-4313.
35. Schut HAJ, Snyderwine EG. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis. Carcinogenesis 1999; 20: 353-368.
36. Stuart GR, Holcroft J, de Boer JG, Glickman BW. Prostate mutations in rats induced by suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Cancer Res 2000; 60: 266-268.
37. Williams JA, Martin FL, Muir GH, Hewer A, Grover PL, Phillips DH et al. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 2000; 21: 1683-1689.
38. Lawson T, Kolar C. Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens. Cancer Lett 2002; 175: 141-146.
39. Martin FL, Cole KJ, Muir GH, Kooiman GG, Williams JA, Sherwood RA et al. Primary cultures of prostate cells and their ability to activate carcinogens. Prostate Cancer Prostatic Dis 2002; 5: 96-104.
40. Di Paolo OA, Teitel CH, Nowell S, Coles BF, Kadlubar FF. Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyle-CoA-, PAPS- and ATP-dependent pathways. Int J Cancer 2005; 117: 8-13.
41. Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent oestrogen: A mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004; 25: 2509-2517.
42. Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D et al. (eds). Racial/Ethic Patterns of Cancer in the United States 1988-1992, NIH Pub. No. 96-4104. National Cancer Institute: Bethesda, MD, 1996.
43. Robbins AS, Whittemore AS, Van Den Eden SK. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst 1998; 90: 986-990.
44. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85 60-67.
45. Schurrman AG, Zeegers PA, Goldbohm RA, van den Brandt PA. A case-control study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 1999; 10: 192-195.
46. Hemminki K, Czene K. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 2002; 95: 1346-1353.
47. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis. Cancer 2003; 97: 1894-1903.
48. Hemminki K, Chen B. Familial association of prostate cancer with other cancers in the Swedish Family-Center Database. Prostate 2005; 65: 188-194.
49. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran M, Mehra R, Sun X-W et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644-648.
50. Hsing AW. Hormones and prostate cancer: What's next? Epidemiol Rev 2001; 23: 42-58.
51. Pettaway CA. Racial differences in the adrogen/androgen receptor pathway in prostate cancer. J Natl Med Assoc 1999; 91: 652-660.
52. Ross RK, Pike MC, Coetzee GA, Reichhardt JKV, Yu MC, Feigelson H et al. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility. Cancer Res 1998; 58: 4497-4504.
53. Minami Y, Staples MP, Giles GG. The incidence of colon, breast and prostate cancer in Italian migrants to Victoria, Australia. Eur J Cancer 1993; 29A: 1735-1740.
54. Mettlin C. Recent developments in the epidemiology of prostate cancer. Eur J Cancer 1997; 33: 340-347.
55. Angwafo FF. Migration and prostate cancer: An international perspective. J Natl Med Assoc 1998; 90 (11 Suppl): S720-S723.
56. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallager RP, Howe GR et al. Prostate cancer in relation to diet, physical activity, and body size in Blacks, Whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652-661.
57. Kolonel LN, Nomura AMY, Cooney RV. Dietary fat and prostate cancer: current status. J Natl Cancer Inst 1999; 91: 414-428.
58. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomark Prev 1999; 8: 25-34.
59. Daniels LK, Snetselaar LG, Smith BJ, Stewart RE, Robbins MEC. Problems with the assessment of dietary fat in prostate cancer studies. Am J Epidemiol 2004; 160: 436-444.
60. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height body weight, and risk of prostate cancer. Cancer Epidemiol Biomark Prevent 1997; 6: 557-563.
61. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998; 58: 442-447.
62. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer. J Natl Cancer Inst 2000; 92: 61-68.
63. Chan J, Giovannucci E. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev 2001; 23: 82-86.
64. Chan J, Giovannucci E. Dairy products, calcium, and vitamin D, and risk of prostate cancer. Epidemiol Rev 2001; 23: 87-92.
65. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: A review of the epidemiological evidence. Nutr Cancer 2002; 42 1-9.
66. Bodiwala, D, Luscombe CJ, Liu S, Saxby M, French M, Jones PW et al. Cancer potencies of heterocyclic amines found in cooked foods. Cancer Lett 2003; 192: 145-149.
67. U.S. Department of Agriculture (USDA). 1994-96 Continuing Survey of Food Intakes by Individuals and 1994-96 Diet and Health Knowledge Survey (CSFII/DHKS 1994-96 Data Set). CD-ROM. USDA Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group: Beltsville, MD, 1998.
68. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort of diet, lifestyle and prostate cancer in Adventist men. Cancer 1989; 64: 598-604.
69. Shiffman MH, Felton JS. Re 'Fried foods and the risk of colon cancer'. Am J Epidemiol 1990; 131: 376-378.
70. Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Õvervik E. Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm. Int J Cancer 1991; 49: 520-525.
71. Talamini R, Franceschi S, La Vecchia C, Serraino D, Negri E. Diet and prostatic cancer: A case-control study in northern Italy. Nutr Cancer 1992; 18: 277-286.
72. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Hensen M et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomark Prev 1994; 8: 675-682.
73. De Stefani E, Fierro L, Barrios E, Ronco A. Tobacco, alcohol, diet and risk of prostate cancer. Tumori 1995; 81: 315-320.
74. Ewings P, Bowie C. A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer 1996; 74: 661-666.
75. Probst-Hensch NM, Sinha R, Longnecker MP, Witte JS, Ingles SA, Frankl HD et al. Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control 1997; 8: 175-183.
76. Ward MH, Sinha R, Heinman EF, Rothman N, Markin R, Weiseriburger DD et al. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997; 71 14-19.
77. Kampman E, Slattery ML, Bigler J, Leppert M, Samowitz W, Caan BJ et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomark Prev 1999; 8: 15-24.
78. Norrish AE, Ferguson LR, Knize MG, Felton JS, Sharpe SJ, Jackson RT. Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst 1999; 91: 2038-2044.
79. Sinha R, Kulldorff M, Curtin. J, Brown CC, Alavanja MC, Swanson C. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control 1998; 9: 621-630.
80. Sinha R, Chow WH, Kulldorff M, Denobile J, Butler J, Garcia-Closas M et al. Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res 1999; 59: 4320-4324.
81. Zheng W, Gustafson DR, Sinha R, Cerhan JR, Moore D, Hong CP et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst 1998; 90: 1724-1729.
82. Sinha R, Rothman N. Role of well-done, grilled red meat, heterocyclic amines (HCAs) in the etiology of human cancer. Cancer Lett 1999; 143: 189-194.
83. Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA et al. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomark Prev 1999; 8: 233-239.
84. Sinha R. An epidemiological approach to studying heterocyclic amines. Mutat Res 2002; 506/507: 197-204.
85. Butler LM, Sinha R, Millikan RC, Martin CF, Newman B, Gammon MD et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 2003; 157 434-445.
86. Chen K, Liang JQ, Zhang Y, Wan YZ. Meta-analysis of risk factors for colorectal cancer. World J Gastroenterol 2003; 9: 1598-1600.
87. Murtaugh MA, Ma K, Sweeney C, Caan BJ Slattery ML. Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women. J Nutr 2004; 134: 776-784.
88. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD et al. Meat consumption and risk of colorectal cancer. JAMA 2005; 293: 233-234.
89. Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Chao A, Patel AV et al. Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomark Prev 2006; 15: 211-216.
90. Sadri GH, Mahjub M. Meat consumption is a risk factor for colorectal cancer: Meta-analysm of case-control studies. Pakistani J Nutr 2006; 5: 230-233.
91. Lyon JL, Mahoney AW. Fried foods and the risk of colon cancer. Am J Epidemiol 1988; 128: 1000-1006.
92. Muscat JE, Wynder EL. The consumption of well-done red meat and the risk of colorectal cancer. Am J Public Health 1994; 84:856-858.
93. Augustsson K, Skog K, Jagerstad M, Dickman PW, Steineck G. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: A population based study. Lancet 1999; 353: 703-707.
94. Delfind RJ, Sinha R, Smith C, West J, White E, Lin HJ et al. Breast cancer, heterocyclic aromatic amines from meat and N acetyltransferase 2 genotype. Carcinogenesis 2000; 21: 607-615.
95. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R et al. Longitudinal evaluation of prostrate-specific antigen levels in men with and without prostrate disease. J Am Med Assoc 1992; 267 2215-2220.
96. Cesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA et al. Senun prostate-specific antigen in a community-based population of healthy men. J Am Med Assoc 1993; 270: 860-864.
97. Etzioni R, Cha R, Cowen M. Serial prostate specific antigen screening for prostate cancer: A computer model evaluates competing strategies. J Urol 1999; 162: 741-748.
98. Abdalla I, Ray P, Vijayakumar S. Race and serum prostate-specific antigen levels: Current status and future directions. Semin Urol Oncol 1998a; 16: 207-213.
99. Abdalla I, Ray P, Ray V, Vaida F, Vijayakumar S. Comparison of serum prostate-specific antigen levels and PSA density in African American, white, and Hispanic men without prostate cancer. Urology 1998b; 51: 300-305.
100. Vijayakumar S, Writer K, Sause W, Gallagher MJ, Michalski J, Roach M et al. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12. Int J Radiat Oncol Biol Biophys 1998; 40: 17-25.
101. Fowler Jr JE, Bigler SA, Kilambi NK, Land SA. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies. Urology 1999; 53: 1175-1178.
102. Määttänen L, Auvinen A, Steriman U-H, Tanunela T, Rannikko S, Aro J et al. Three-year results of the Finnish Prostate Cancer Screening Trial. J Natl Cancer Inst 2001; 93: 552-553.
103. Gerstenbluth RE, Seftel AD, Hampel N, Oefelein MG, Resnick MI. The accuracy of the increased prostate specific antigen level (greater than or equal to 20ng/ml.) in predicting prostate cancer: Is biopsy always required? J Urol 2002; 168: 1990-1993.
104. Snuth RP, Malkowicz, SB, Whittington R, VanArsdalen K, Tochner Z, Wein AJ. Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med 2004, 164 1227-1230.
105. Vollmer RT. Predictive probability of serum prostate-specific antigen for prostate cancer: An approach using Bayes rule. Clin Chem 2006; 125: 336-342.
106. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parries HL et al. Prevalence of prostate cancer among men with a prostate-specific antigen level
107. American Cancer Society (ACS). California Cancer Facts and Figures, 2006. ACS California Division and Public Health Institute California Cancer Registry: Oakland, CA, 2005.
108. US Census Bureau. State and County QuickFacts (http://quickfacts.census.gov/qfd/states/06000.html, revised 8 June 2006)
109. and American FactFinder, 2005 American Community Survey, custom tables B12002B, B01002B, B20017B (http://factfinder.census.gov): 2006.
110. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124: 453-469.
111. Sinha R, Rothman N, Salmon CP, Knize MG, Brown ED, Swanson CA et al. Heterocyclic amine content in beef cooked by different methods and to varying degrees of doneness and gravy made from meat drippings. Food Chem Toxicol 1998; 36: 279-287.
112. Sinha R, Knize MG, Salmon CP, Brown ED, Rhodes D, Felton JS et al. Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. Food Chem Toxicol 1998; 36 289-297.
113. Cantwell M, Mittl B, Curtin J, Carrol. R, Potischman N, Caporaso N et al. Relative validity of a food frequency questionnaire with a meat-cooking and heterocyclic amine module. Cancer Epidemiol Biomark Prev 2004; 13: 293-298.
114. Bogen KT, Keating GA. US dietary exposures to heterocyclic amines. J Exposure Anal Environ Epidemiol 2001; 11: 155-168.
115. Keating GA, Bogen KT. Methods to estimate heterocyclic amine concentrations in cooked meats in the U.S. diet. Food Chem Toxicol 2001; 39: 29-43.
116. Keating GA, Bogen KT. Estimates of heterocyclic amine intake in the U.S. population. J Chromatogr B 2004; 802: 127-133.
117. Draper NR, Smith H. Applied Regression Analysis, 2nd edn. John Wiley & Sons: New York, NY, 1981.
118. Selvin S. Practical Biostatistical Methods. Duxbury Press: New York, NY, 1995.
119. Kendall M, Stuart A. The Advanced Theory of Statistics, vol. 2. MacMillan Publishing Co.: New York, NY, 1979, pp 159-160.
120. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II - The Design and Analysis of Cohort Studies, IARC Scientific Publ. No. 82. International Agency for Cancer research (IARC): Lyon, France, 1987, pp 106-118.
121. Wolfram S. Mathematica Book, 4th edn. Cambridge University Press: Cambridge, UK, 1999.
122. Kidd LR, Stillwell WG, Yu MC, Wishnok JS, Skipper PL, Ross RK et al. Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine (PhIP) in White, African American, and Asian-American men in Los Angeles County. Cancer Epidemiol Biomark Prev 1999; 8: 439-445.
123. 14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis 1999, 20: 705-713.
124. U.S. Department of Agriculture (USDA). 1989-91 Continuing Survey of Food Intakes by Individuals and 1989-91 Diet and Health Knowledge Survey (CSFII/DHKS 1989-91 Data Set). CD-ROM. USDA Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group: Beltsville, MD, 1993.
125. Zelterman D. Models for Discrete Data. Clarendon Press: Oxford, UK, 1999, pp 6-24.
126. Wilkens LR, Hankin JH, Yoshizawa CN, Kolonel LN, Lee J. Comparison of long-term dietary recall between cancer cases and noncases. Am J Epidemiol 1992; 136: 825-835.
127. Stark A. An historical review of the Harvard and the National Cancer Institute Food Frequency Questionnaires: Their simiarities, differences, and their limitations in assessment of food intake. Ecol Food Nutr 2002; 41: 35-74.
128. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires - The eating at America's table study. Am J Epidemiol 2001; 154: 1089-1099.